Selskabets formål er bedrive forskning og ydelse af tjenester til udvikling af humane lægemidler.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 4.7 mio. | 373 t. | 6.1 mio. | 1.3 mio. | 2 | |
CVR: 43329545
Yael Gruenbaum Cohen left the board
Stephanie Galantine-Heller joined the board
Yael Gruenbaum Cohen joined the board
Norbert Wolfgang Bischofberger joined the board
Gur-Arye Yehuda Roshwalb left the board
Compared to 131 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Companies in the same industry and area
companydata.dk